(S)he said what?!?
Diabetes & Weight Loss News
37 readers recommended
Larry Soler and Dr. James Gavin discuss Partnership for a Healthier America's efforts to fight childhood obesity.
36 readers recommended
Several months after an FDA advisory committee delivered an overwhelmingly positive vote (20-2) in favor of approving Vivus’ Qnexa for the treatment of obesity, the...
37 readers recommended
In previous issues, we’ve documented the arduous journey of Orexigen’s anti-obesity drug Contrave through the regulatory process. In December, an FDA Advisory Committee...
25 readers recommended
On May 14, HBO premiered its four-part documentary series on obesity, The Weight of the Nation . Each part – entitled “Consequences,” “Choices,” “Children in Crisis,”...
37 readers recommended
Novo Nordisk’s Head of China Ron Christie divulges details on the state of diabetes care in the world’s most populous nation.
32 readers recommended
The Obesity Society's annual meeting has long been our favorite place to catch up on the basic science research behind this critical problem.
32 readers recommended
If you’ve been following our coverage of Orexigen’s obesity drug, Contrave, you’re likely aware that it has been through a regulatory rollercoaster over the past few...
59 readers recommended
Over the past several years, the use of GLP-1 drugs (such as Byetta and Victoza) together with basal insulins (such as Lantus and Levemir) as a treatment for type 2...
22 readers recommended
Recently, increasing evidence has suggested that weight-loss surgery (called “bariatric surgery”) can help improve type 2 diabetes management (or even cause its reversal...
36 readers recommended
In late November, the Centers for Medicare and Medicaid Services (the federal agency that administers the two public insurance programs) announced that Medicare would...
34 readers recommended
The giant Consumer Electronics Show, held each January in Las Vegas, had a variety of devices relevant to diabetes and obesity this year. Media buzz surrounded the...
38 readers recommended
On September 17, Vivus announced that its obesity medication Qsymia (formerly Qnexa) is now available on the US market – this happened at least several weeks earlier...
29 readers recommended
What really causes weight gain? A fascinating review in the New England Journal of Medicine details myths and facts about obesity.
33 readers recommended
Exercise and weight loss have been shown to significantly reduce a person’s risk of moving from prediabetes to type 2 diabetes. However, insurance coverage for these...
22 readers recommended
Kelly on the shocking new data just released on diabetes costs and what we can do about it.
35 readers recommended
During the US Open tennis tournament earlier this month, Larry Soler of the Partnership for a Healthier America (PHA) announced a pair of new initiatives to promote...
30 readers recommended
James Hirsch assesses the implications for diabetes from the bestseller Salt Sugar Fat .
36 readers recommended
Retrofit CEO Jeff Hyman explains what makes data-driven weight loss – using Skype sessions and Wifi scales– so different.
47 readers recommended
The 30th Annual Obesity Society Meeting brings exciting insights on drugs and mobile health.